[1]Patent:US2012/244110,2012,A1
[2]JournalofMedicinalChemistry,2014,vol.57,p.3430-3449
[1]Patent:US2012/244110,2012,A1
[2]JournalofMedicinalChemistry,2014,vol.57,p.3430-3449
[1]Patent:US2012/244110,2012,A1
[2]JournalofMedicinalChemistry,2014,vol.57,p.3430-3449
[3]OrganicProcessResearchandDevelopment,2015,vol.19,p.476-485
[1]JournalofMedicinalChemistry,2014,vol.57,p.3430-3449
[2]OrganicProcessResearchandDevelopment,2015,vol.19,p.476-485
Title: Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor for treating acute myeloid leukemia.
Journal: Molecular cancer therapeutics 20140401
Title: Keegan K, et al. Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor for treating acute myeloid leukemia. Mol Cancer Ther. 2014 Apr;13(4):880-9.